MHAA4549A Uses, Dosage, Side Effects and more

MHAA4549A is under investigation in clinical trial NCT01877785 (A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers).

Trade Name MHAA4549A
Generic Gedivumab
Gedivumab Other Names Gedivumab, MHAA4549A
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share